A new drug developed by scientists at the Florey Institute of Neuroscience, and the School of Chemistry and Bio21 Institute at the University of Melbourne has dramatically improved clinical and cognitive symptoms of motor neurone disease, also called amyotrophic lateral sclerosis.
Motor neurone disease is a progressive, fatal neurodegenerative disease. Its key hallmark is the death of the brain cells that control muscle movements. This results in muscle weakness and eventually paralysis.
Patients usually die of respiratory failure within three years of diagnosis, and there are no treatments or disease-modifying therapies available.
In this dose-finding trial involving 32 patients, the group given the highest amount of the CuATSM compound showed improved lung function and cognitive ability, compared to the predicted declines observed in standard-of-care patients.
Further, treated patients showed a much slower overall disease progression as measured by a global disability score.
The clinical trial was led by Professor Dominic Rowe at Macquarie University, and Associate Professor Susan Mathers at Calvary Health Care Bethlehem, and sponsored by Collaborative Medicinal Development Pty Ltd with support from FightMND.
Professor Ashley Bush, Chief Scientific Officer of Collaborative Medicinal Development and director of the Melbourne Dementia Research Centre, said “This is the first human evidence for a disease-modifying drug for motor neurone disease. It is a huge breakthrough, and we look forward to confirming the positive results in a larger study soon.”
Associate Professor Kevin Barnham of the Florey, Associate Professor Anthony White at the Queensland Institute of Medical Research, and Professor Paul Donnelly and Associate Professor Peter Crouch from the University of Melbourne, developed and tested CuATSM over a 15-year period.
After showing its therapeutic potential for motor neurone disease in pre-clinical models, the researchers founded a company and licenced the compound to Collaborative Medicinal Development, to take the drug into human studies.
Professor Donnelly said, “It is gratifying to see such promising results made possible by collaborative fundamental research at the interface between chemistry and biology.”
Learn more: Motor neurone disease breakthrough: Patient trial shows impressive clinical results
The Latest on: Motor neurone disease
[google_news title=”” keyword=”motor neurone disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Motor neurone disease
- Differentiating cerebral cortical neurons to decipher molecular mechanisms of neurodegenerationon April 25, 2024 at 8:10 am
A research team led by Professor Haruhisa Inoue (Department of Cell Growth and Differentiation) derived iPS cells (iPSC) from α-synucleinopathy patients with early-onset familial Parkinson's disease ...
- New drug may help reduce signs of motor deterioration in Parkinson'son April 25, 2024 at 4:15 am
Prasinezumab, an experimental monoclonal antibody treatment, may help reduce the deterioration of motor skills in people with rapidly progressing Parkinson’s disease, a new study suggests.
- Pongakawa’s James Wilkins’ US Coast to Coast odyssey to Motor Neurone Disease NZon April 24, 2024 at 11:00 am
Pongakawa’s James Wilkins is cycling across the US in support of Motor Neurone Disease New Zealand. There’s the Coast to Coast - then there’s the Coast to Coast, US style. Pongakawa’s James Wilkins ...
- Motor neurone disease: How you can help Kiwis living with MNDon April 22, 2024 at 11:25 am
Recognising the power of kōrero, Motor Neurone Disease NZ is highlighting the disease, and again launching its fundraising initiatives: Cuppa Tea for MND and the iconic MND Ice Bucket Challenge to ...
- What is MND? Motor Neurone Disease explained as Rob Burrow continues fighton April 19, 2024 at 4:00 pm
Dr Brian Dickie, director of research at the Motor Neurone Disease Association, said: “It often takes a year from the first onset of symptoms to receiving a diagnosis of MND.” But he said “innovative ...
- Motor Neurone Disease - unique challenge to raise awarenesson April 19, 2024 at 10:30 am
Cookie choices We use cookies and similar technologies to provide our services and to measure and improve your experience. If you choose ‘Accept’, the online marketing you see about ITV will be more ...
- Motor Neuron Disease Drug Pipeline Research 2024: Comprehensive Insights About 180+ Companies and 200+ Pipeline Drugson April 16, 2024 at 2:11 am
The "Motor Neuron Disease - Pipeline Insight, 2024" drug pipelines has been added tAndMarkets.com's offering.This "Motor Neuron Disease- Pipeline Insight, 2024" report provides comprehensive insights ...
- Motor neurone disease: 'Game-changer' treatment soon available in New Zealandon April 15, 2024 at 12:44 am
Every week in New Zealand two people will be diagnosed with motor neurone disease and two people die from it. About 400 people are tonight battling it. There's no known cure yet. But a treatment - ...
- Symptoms of ALS or Lou Gehrig's Diseaseon April 14, 2024 at 5:00 pm
ALS is considered a motor neuron disease. Lou Gehrig was a baseball player in the 1930s whose career was cut short at age 36 by the condition. He died less than 2 years later. It can show up ...
- Member for Pakenham Emma Vulin reveals she is in the early stages of motor neurone diseaseon April 13, 2024 at 5:00 pm
In short: Victorian Labor MP Emma Vulin has revealed she is in the early stages of motor neurone disease (MND). MND is a progressive, terminal illness that damages the nervous system. Ms Vulin ...
via Bing News